Protein carbonyl and the methionine sulfoxide reductase system

Antioxidants and Redox Signaling

Volumn 12, Issue 3, 2010, Pages 405-415

  Moskovitz, Jackob ^a   Oien, Derek B ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMINO ACID; CARBONYL DERIVATIVE; METHIONINE SULFOXIDE REDUCTASE; PROTEIN; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; DEGENERATIVE DISEASE; GENE OVEREXPRESSION; HUMAN; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN MODIFICATION; REVIEW; YEAST;

AGING; ANIMALS; HUMANS; METHIONINE; MICE; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; OXIDOREDUCTASES; PROTEIN CARBONYLATION;

MUS;

EID: 75149114580     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2809     Document Type: Review

References (87)

1. Aguilaniu H, Gustafsson L, Rigoulet M, and Nystrom T. Asymmetric inheritance of oxidatively damaged proteins during cytokinesis. Science 299: 1751-1753, 2003.
2. Aksenov MY, Aksenova MV, Payne RM, Smith CD, Mar-kesbery WR, and Carney JM. The expression of creatine kinase isoenzymes in neocortex of patients with neurode-generative disorders: Alzheimer's and Pick's disease. Exp Neurol 146: 458-465, 1997.
3. Amici A, Levine RL, Tsai L, and Stadtman ER. Conversion of amino acid residues in proteins and amino acid homopoly-mers to carbonyl derivatives by metal-catalyzed oxidation reactions. J Biol Chem 264: 3341-3346, 1989.
4. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, and Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152: 879-884, 1998. (Pubitemid 28173348)
5. Bar-Noy S and Moskovitz J. Mouse methionine sulfoxide reductase B: effect of selenocysteine incorporation on its activity and expression of the seleno-containing enzyme in bacterial and mammalian cells. Biochem Biophys Res Commun 297: 956-961, 2002.
6. Bar-Shai M, Carmeli E, Ljubuncic P, and Reznick AZ. Exercise and immobilization in aging animals: the involvement of oxidative stress and NF-kappaB activation. Free Radic Biol Med 44: 202-214, 2008.
7. Baynes JW and Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9, 1999.
8. Beal MF. Energy, oxidative damage, and Alzheimer's disease: clues to the underlying puzzle. Neurobiol Aging 15(suppl 2): S171-S174, 1994.
9. Beckman KB and Ames BN. The free radical theory of aging matures. Physiol Rev 78: 547-581, 1998.
10. Berke SJ and Paulson HL. Protein aggregation and the ubi-quitin proteasome pathway: gaining the upper hand on neurodegeneration. Curr Opin Genet Dev 13: 253-261, 2003.
11. Bigelow DJ and Squier TC. Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins. Biochim Biophys Acta 1703: 121-134, 2005.
12. Burbaeva, G. [Physiologically active brain proteins as possible markers of mental diseases]. Vestn Ross Akad Med Nauk 7: 51-54, 1992.
13. Butterfield DA and Boyd-Kimball D. The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta 1703: 149-156, 2005.
14. Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, and But-terfield DA. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain, Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33: 562-571, 2002.
15. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, and Butterfield DA. Pro-teomic identification of oxidatively modified proteins in Alzheimer's disease brain, Part II: dihydropyrimidinase- related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82: 1524-1532, 2002.
16. Chen Q, Ding Q, and Keller JN. The stationary phase model of aging in yeast for the study of oxidative stress and age-related neurodegeneration. Biogerontology 6: 1-13, 2005.
17. Chen Q, Thorpe J, Ding Q, El-Amouri IS, and Keller JN. Proteasome synthesis and assembly are required for survival during stationary phase. Free Radic Biol Med 37: 859-868, 2004.
18. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, and Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 279: 13256-13264, 2004.
19. Dawson TM and Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822, 2003.
20. Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G, and Carey PR. Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42: 2768-2773, 2003.
21. Esterbauer H, Schaur RJ, and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128, 1991.
22. Fink AL. The aggregation and fibrillation of alpha-synuclein. Acc Chem Res 39: 628-634, 2006.
23. Gabbita SP, Aksenov MY, Lovell MA, and Markesbery WR. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J Neurochem 73: 1660-1666, 1999.
24. Garland D, Russell P, and Zigler JS Jr. The oxidative modification of lens proteins. Basic Life Sci 49: 347-352, 1988.
25. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, and Lee VM. Oxida-tive damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290: 985-989, 2000.
26. Giorgi FS, Bandettini di Poggio A, Battaglia G, Pellegrini A, Murri L, Ruggieri S, Paparelli A, and Fornai F. A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease. J Neural Transm Suppl 70: 105-109, 2006.
27. Grune T, Merker K, Jung T, Sitte N, and Davies KJ. Protein oxidation and degradation during postmitotic senescence. Free Radic Biol Med 39: 1208-1215, 2005.
28. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Ak-senov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, Lovell M, Markesbery WR, and Butterfield A. Brain regional correspondence between Alzheimer's disease histopathol-ogy and biomarkers of protein oxidation. J Neurochem 65: 2146-2156, 1995.
29. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, and Masliah E. alpha-synuclein promotes mitochondrial deficit and oxida-tive stress. Am J Pathol 157: 401-410, 2000.
30. Ishii N. Oxidative stress and aging in Caenorhabditis elegans. Free Radic Res 33: 857-864, 2000.
31. Jakubowski W, Bilinski T, and Bartosz G. Oxidative stress during aging of stationary cultures of the yeast Sacchar-omyces cerevisiae. Free Radic Biol Med 28: 659-664, 2000.
32. Kabuta T, Setsuie R, Mitsui T, Kinugawa A, Sakurai M, Aoki S, Uchida K, and Wada K. Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum Mol Genet 17: 1482-1496, 2008.
33. Kristal BS and Yu BP. An emerging hypothesis: synergistic induction of aging by free radicals and Maillard reactions. J Gerontol 47: B107-B114, 1992.
34. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108, 1998.
35. Levine RL, Mosoni L, Berlett BS, and Stadtman ER. Me-thionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci USA 93: 15036-15040, 1996.
36. Lindersson E, Beedholm R, Hojrup P, Moos T, Gai W, Hendil KB, and Jensen PH. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J Biol Chem 279: 12924-12934, 2004.
37. Lucking CB and Brice A. Alpha-synuclein and Parkinson's disease. Cell Mol Life Sci 57: 1894-1908, 2000.
38. Luo S and Levine RL. Methionine in proteins defends against oxidative stress. FASEB J 23: 464-472, 2009.
39. Markesbery WR and Carney JM. Oxidative alterations in Alzheimer's disease. Brain Pathol 9: 133-146, 1999.
40. Martinez-Vicente M, Sovak G, and Cuervo AM. Protein degradation and aging. Exp Gerontol 40: 622-633, 2005.
41. McMurray MA and Gottschling DE. An age-induced switch to a hyper-recombinational state. Science 301: 1908-1911, 2003.
42. Moskovitz, J. Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases. Biochim Biophys Acta 1703: 213-219, 2005.
43. Moskovitz J. Prolonged selenium-deficient diet in MsrA knockout mice causes enhanced oxidative modification to proteins and affects the levels of antioxidant enzymes in a tissue-specific manner. Free Radic Res 41: 162-171, 2007.
44. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, and Stadtman ER. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA 98: 12920-12925, 2001.
45. Moskovitz J, Berlett BS, Poston JM, and Stadtman ER. The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. Proc Natl Acad Sci USA 94: 9585-9589, 1997.
46. Moskovitz J, Flescher E, Berlett BS, Azare J, Poston JM, and Stadtman ER. Overexpression of peptide-methionine sulf-oxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc Natl Acad Sci USA 95: 14071-14075, 1998.
47. Moskovitz J, Jenkins NA, Gilbert DJ, Copeland NG, Jursky F, Weissbach H, and Brot N. Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc Natl Acad Sci USA 93: 3205-3208, 1996.
48. Moskovitz J, Singh VK, Requena J, Wilkinson BJ, Jayaswal RK, and Stadtman ER. Purification and characterization of methionine sulfoxide reductases from mouse and Staphylo-coccus aureus and their substrate stereospecificity. Biochem Biophys Res Commun 290: 62-65, 2002.
49. Moskovitz J and Stadtman ER. Selenium-deficient diet enhances protein oxidation and affects methionine sulfoxide reductase (MsrB) protein level in certain mouse tissues. Proc Natl Acad Sci USA 100: 7486-7490, 2003.
50. Moskovitz J, Yim MB, and Chock PB. Free radicals and disease. Arch Biochem Biophys 397: 354-359, 2002.
51. Munishkina LA, Henriques J, Uversky VN, and Fink AL. Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation. Biochemistry 43: 3289-3300, 2004.
52. Oien D and Moskovitz J. Protein-carbonyl accumulation in the non-replicative senescence of the methionine sulfoxide reductase A (msrA) knockout yeast strain. Amino Acids 32: 603-606, 2007.
53. Oien D, Wang X, and Moskovitz J. Genomic and sulfox-ide reductase a knockout mouse. Curr Proteomics 5: 96-103, 2008.
54. Oien DB and Moskovitz J. Substrates of the methionine sulfoxide reductase system and their physiological relevance. Curr Top Dev Biol 80: 93-133, 2008.
55. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, and Stadt-man ER. Age-related changes in oxidized proteins. J Biol Chem 262: 5488-5491, 1987.
56. Oliver CN, Starke-Reed PE, Stadtman ER, Liu GJ, Carney JM, and Floyd RA. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia=reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci USA 87: 5144-5147, 1990.
57. Outeiro TF and Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302: 1772-1775, 2003.
58. Pal R, Oien DB, Ersen FY, and Moskovitz J. Elevated levels of brain pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp Brain Res 180: 765-774, 2007.
59. Palmblad M, Westlind-Danielsson A, and Bergquist J. Oxidation of methionine 35 attenuates formation of amyloid beta-peptide 1-40 oligomers. J Biol Chem 277: 19506-19510, 2002.
60. Perrone GG, Grant CM, and Dawes IW. Genetic and environmental factors influencing glutathione homeostasis in Saccharomyces cerevisiae. Mol Biol Cell 16: 218-230, 2005.
61. Pocsi I, Prade RA, and Penninckx MJ. Glutathione, altruistic metabolite in fungi. Adv Microb Physiol 49: 1-76, 2004.
62. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papape-tropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, and Nussbaum RL. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047, 1997.
63. Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, and Butterfield DA. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice: a model of familial Parkinson's disease. Neurobiol Dis 18: 492-498, 2005.
64. Rhee SG. Redox signaling: hydrogen peroxide as intracel-lular messenger. Exp Mol Med 31: 53-59, 1999.
65. Sawada H, Kohno R, Kihara T, Izumi Y, Sakka N, Ibi M, Nakanishi M, Nakamizo T, Yamakawa K, Shibasaki H, Ya-mamoto N, Akaike A, Inden M, Kitamura Y, Taniguchi T, and Shimohama S. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions. J Biol Chem 279: 10710-10719, 2004.
66. Schoneich C. Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. Biochim Biophys Acta 1703: 111-119, 2005.
67. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, and Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302: 841, 2003.
68. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, and Markesbery WR. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88: 10540-10543, 1991.
69. Smith MA, Rudnicka-Nawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, Sayre LM, and Perry G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 64: 2660-2666, 1995.
70. Snyder H, Mensah K, Hsu C, Hashimoto M, Surgucheva IG, Festoff B, Surguchov A, Masliah E, Matouschek A, and Wolozin B. beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein. J Biol Chem 280: 7562-7569, 2005.
71. Sohal RS, Agarwal S, and Sohal BH. Oxidative stress and aging in the Mongolian gerbil (Meriones unguiculatus). Mech Ageing Dev 81: 15-25, 1995.
72. Stadtman ER and Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 10: 485-494, 1997.
73. Stadtman ER, Moskovitz J, Berlett BS, and Levine RL. Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol Cell Biochem 234-235: 3-9, 2002.
74. Stadtman ER, Moskovitz J, and Levine RL. Oxidation of methionine residues of proteins: biological consequences. Antioxid Redox Signal 5: 577-582, 2003.
75. Stadtman ER, Starke-Reed PE, Oliver CN, Carney JM, and Floyd RA. Protein modification in aging. EXS 62: 64-72, 1992.
76. Starke-Reed PE and Oliver CN. Protein oxidation and pro-teolysis during aging and oxidative stress. Arch Biochem Biophys 275: 559-567, 1989.
77. Taborsky G. Oxidative modification of proteins in the presence of ferrous ion and air: effect of ionic constituents of the reaction medium on the nature of the oxidation products. Biochemistry 12: 1341-1348, 1973.
78. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, and Masliah E. Abnormal accumulation of NACP=alpha-synuclein in neurodegenerative disorders. Am J Pathol 152: 367-372, 1998.
79. Taylor JP, Hardy J, and Fischbeck KH. Toxic proteins in neurodegenerative disease. Science 296: 1991-1995, 2002.
80. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
81. Uchida K and Stadtman ER. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydro-genase: a possible involvement of intra-and intermolecular cross-linking reaction. J Biol Chem 268: 6388-6393, 1993.
82. Umstead TM, Freeman WM, Chinchilli VM, and Phelps DS. Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat. Am J Physiol Lung Cell Mol Physiol 296: L14-L29, 2009.
83. Uversky VN, Yamin G, Souillac PO, Goers J, Glaser CB, and Fink AL. Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. FEBS Lett 517: 239-244, 2002.
84. Vekrellis K, Rideout HJ, and Stefanis L. Neurobiology of alpha-synuclein. Mol Neurobiol 30: 1-21, 2004.
85. Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, and Muchowski PJ. Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein. Science 302: 1769-1772, 2003.
86. Witt SN and Flower TR. alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease. FEMS Yeast Res 6: 1107-1116, 2006.
87. Yamin G, Glaser CB, Uversky VN, and Fink AL. Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein. J Biol Chem 278: 27630-27635, 2003.